Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to compare the efficacy and safety of influenza vaccine
in patients with inflammatory bowel disease (IBD) receiving immunosuppressive therapy with
patients not receiving immunosuppressants .
The main objective of the study is to evaluate the humoral immunogenicity of influenza
vaccination in patients with IBD
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
Institut National de la Santé Et de la Recherche Médicale, France Institut Pasteur Pierre and Marie Curie University University of Paris 5 - Rene Descartes